Skip to main content
65°
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Autolus Therapeutics Plc ADR
(NQ:
AUTL
)
4.405
-0.035 (-0.79%)
Streaming Delayed Price
Updated: 11:12 AM EDT, Oct 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Autolus Therapeutics Plc ADR
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 21, 2022
Gainers Scopus BioPharma (NASDAQ:SCPS) stock moved upwards by 10.9% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.3 million.
Via
Benzinga
Recap: Autolus Therapeutics Q2 Earnings
August 04, 2022
Autolus Therapeutics (NASDAQ:AUTL) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study
May 05, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap: Autolus Therapeutics Q4 Earnings
March 10, 2022
Autolus Therapeutics (NASDAQ:AUTL) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement....
Via
Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares...
Via
Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (...
Via
Benzinga
40 Stocks Moving In Monday's Mid-Day Session
December 13, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares climbed 83.4% to $91.52. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-cash transaction....
Via
Benzinga
58 Biggest Movers From Yesterday
December 14, 2021
Gainers Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) shares jumped 80.4% to close at $90.08 on Monday. Pfizer agreed to acquire Arena Pharmaceuticals for $100 per share in an all-...
Via
Benzinga
Why Autolus Therapeutics Stock Jumped 25% Today
November 08, 2021
A private equity firm is taking a $100 million stake in the biotech.
Via
The Motley Fool
Mid-Afternoon Market Update: eHealth Drops Following Q3 Results; Autolus Therapeutics Shares Gain
November 08, 2021
Toward the end of trading Monday, the Dow traded up 0.12% to 36,372.57 while the NASDAQ rose 0.23% to 16,009.02. The S&P also rose, gaining 0.07% to 4,700.74. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
64 Biggest Movers From Yesterday
November 09, 2021
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile...
Via
Benzinga
Mid-Day Market Update: Trade Desk Jumps After Upbeat Results; GT Biopharma Shares Slide
November 08, 2021
Midway through trading Monday, the Dow traded up 0.34% to 36,452.79 while the NASDAQ rose 0.18% to 16,000.97. The S&P also rose, gaining 0.11% to 4,702.76. The U.S. has the...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
38 Stocks Moving In Monday's Mid-Day Session
November 08, 2021
Gainers Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares climbed 129.8% to $7.49 after the company announced the launch of its E-Boost portfolio of mobile Electric Vehicle...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 08, 2021
Gainers PetVivo Holdings (NASDAQ:PETV) s...
Via
Benzinga
DSAC Stock Pops on FiscalNote SPAC Merger News. 14 Things to Know.
November 08, 2021
Duddell Street Acquisition (DSAC) stock is on the move Monday following news of a special purpose acquisition company merger with FiscalNote.
Via
InvestorPlace
Chinese Stocks Alert: The Turnaround Story Driving TAL, EDU, METX, GOTU Stocks Higher
November 08, 2021
Chinese education stocks are moving higher on Monday as reports claim China will allow companies to resume their after-school tutoring.
Via
InvestorPlace
AUTL Stock: Why Little-Known Autolus Therapeutics Is Rocketing Higher Today
November 08, 2021
Autolus Therapeutics (AUTL) stock is surging higher in trading Monday following news of a major investment in the company.
Via
InvestorPlace
Mid-Morning Market Update: Markets Rise; Coty Posts Upbeat Earnings
November 08, 2021
Following the market opening Monday, the Dow traded up 0.40% to 36,472.70 while the NASDAQ rose 0.20% to 16,003.39. The S&P also rose, gaining 0.15% to 4,704.42. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 08, 2021
Gainers Autolus Therapeutics (NASDAQ:AUTL) stock rose 21.04% to $6.73 during Monday's pre-market session. The company's market cap stands at $490.7 million. As per...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 08, 2021
Welcome back, trader! We're starting off the week strong with a dive into the biggest pre-market stock movers for Monday.
Via
InvestorPlace
26 Stocks Moving in Monday's Pre-Market Session
November 08, 2021
Gainers Autolus Therapeutics plc (NASDAQ: AUTL) rose 32.6% to $7.37 in pre-market trading. Syncona said Blackstone Life Science will invest $250 million in Autolus. Mainz Biomed...
Via
Benzinga
Autolus Stock Rallies On $250M Investment From Blackstone
November 08, 2021
Blackstone Inc (NYSE: BX) will invest $250 million in Autolus Therapeutics plc (NASDAQ: AUTL) to fund the final stages of developing a new therapy to...
Via
Benzinga
Allogene Craters To 52-Week Low On FDA Clinical Hold Of CAR-T Trials, Drags Peers As Well
October 08, 2021
The FDA has sent shockwaves through the off-the-shelf CAR-T space after it slapped a clinical hold on all of the Allogene Therapeutics Inc (NASDAQ: ALLO)...
Via
Benzinga
Exposures
Product Safety
Autolus' Blood Cancer CAR T-Cell Therapy Receives Promising Innovative Medicine In UK
August 09, 2021
The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) has granted Promising Innovative Medicine (PIM) designation to Autolus Therapeutics plc's...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 02, 2021
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock increased by 35.01% to $5.5 during Monday's regular session. Trading volume for Xenetic Biosciences's stock is 10.1...
Via
Benzinga
Here's Why Autolus Therapeutics Is Surging Today
August 02, 2021
Potential licensing agreements with Moderna are giving investors reasons to cheer.
Via
The Motley Fool
Autolus Stock Jumps On Cancer mRNA Therapeutics Agreement With Moderna
August 02, 2021
Autolus Therapeutics plc (NASDAQ: AUTL) has granted Moderna Inc (NASDAQ: MRNA) an exclusive license to develop and commercialize mRNA therapeutics...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 02, 2021
Gainers Exicure (NASDAQ:XCUR) stock moved upwards by 35.55% to $1.83 during Monday's pre-market session. The company's market cap stands at $161.0 million....
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.